Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

AstraZeneca-backed studies reveal constant risk of CV events and death

pharmaceuticalAugust 30, 2018

Tag: myocardial infarction , AstraZeneca , CV events

PharmaSources Customer Service